Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-11-26

Clinical Trial Update: A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating greater occipital nerve block for acute migraine attacks has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Jefferson University | Conditions: Migraine | Phase 4 | Status: WITHDRAWN